Atenolol versus losartan in children and young adults with Marfan's syndrome.
New England Journal of Medicine.
Times cited: 241
Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.
American Heart Journal.
Times cited: 191